PR Newswire
PORTLAND, Ore., May 11, 2026
Growing awareness about the health risks associated with excessive weight, such as heart disease, diabetes, and hypertension, has accelerated the adoption of weight management solutions worldwide. Moreover, the expanding availability of digital platforms, offering virtual fitness programs, diet plans, and personalized tracking, is further driving the market
PORTLAND, Ore., May 11, 2026 /PRNewswire/ — Allied Market Research published a report titled,» Weight Management Market Size was valued at USD 144.6 billion in 2023 and is projected to reach USD 381.5 billion by 2033, growing at a CAGR of 10.3% from 2023 to 2033. The increasing prevalence of obesity, rising health awareness, and the growing demand for weight loss solutions are the major factors driving the growth of the weight management market. In addition, advancements in technology, the rise of personalized nutrition, and the growing trend of fitness and wellness are contributing to market expansion.
https://mma.prnewswire.com/media/636519/5963419/Allied_Market_Research_Logo.jpg
Request Sample of the Report on Weight Management Market Forecast 2033 – https://www.alliedmarketresearch.com/request-sample/A14387
Market Size & Growth
The Global weight management service is shortening one of the liveliest vehicles of increase in human historical past due to a once-in-a-century convergence of problems and alternatives surrounding public fitness, pharmacy innovation, and changes in patron lifestyles. The Allied Market Research report shows a market growing from USD 144.6 billion in 2023 with an exponential ascent that want end before hitting USD 381.5 billion by 2033 more than a 2.6x growth buoyed by a solid over a decade 10.3% CAGR.
This remarkable health trend stems from an obesity crisis of epic proportions. Obesity rates have nearly tripled since 1975, according to the World Health Organization, and billions of adults around the world are now considered overweight or obese. Obesity has been established as a chronic disease that drastically increases the risk for type 2 diabetes, cardiovascular disease, hypertension, sleep apnea and many cancers conditions that are major burdens to health systems globally with individuals encouraged or forced at government level into weight management programs.
Key Market Insights
According to the Allied Market Research weight management market report, several high-impact forces shape direction growth during 2023-2033 are:
The GLP-1 Drug Revolution Mass uptake of GLP-1 receptor agonist drugs such as Wegovy and Ozempic has challenged conventional approaches to weight management. As FDA approval expands coverage in the USA for obesity indications, and governments claw back coverage of these drugs under national health plans, prescription obesity drug class now serves as a key revenue driver which has attracted pharmaceutical companies, telehealth platforms and insurers into the market.
Digital Health & Online Weight Loss Programs: Virtual coaching, AI-driven diet tracking apps, and online weight management subscriptions are all on the rise. As more platforms such as Noom, MyFitnessPal, and WW (formerly Weight Watchers) create purely digital-rendered behavioral weight control assistance, previously inaccessible professional care for weight-related behaviors may become democratized and displace traditional clinical services limited by geography and/or budget constraints.
Millenninal & Gen Z are becoming more health conscious: There is a growing trend in younger consumer demographics towards a preventive lifestyle, functional fitness, and clean-label nutrition. Such trends are driving demand for dietary supplements, protein-fortified meal replacements, fitness devices and wellness memberships greatly widening the serviceable addressable market away from only clinical obesity treatment.
Increased/Bariatric Surgery Procedures: Global bariatric surgery volumes are rising as technologies; minimally invasive surgical techniques evolve, and obesity-associated comorbidities become worse. The expanding patient pool selecting surgical weight control structures are approached to be fuelled by expanded post-operative follow-up results and developing consciousness of long-haul weight upkeep following medical procedures.
Personalized Nutrition & Functional Beverages: Consumer focus is quickly moving towards custom nutrition plans based on an individual’s metabolic profile, genetic markers, and lifestyle factors. Products like green tea, weight management drinks, protein powders, and other nutraceuticals that help boost metabolism are proving popular with wide demographic giving global consumers easy access for weight loss efforts.
Want to Explore More, Connect to our Analyst –
https://www.alliedmarketresearch.com/connect-to-analyst/A14387
Market Segmentation
The weight management market report by Allied Market Research segments the industry into function Diet, Fitness Equipment, Surgical Equipment and Services, offering a multi-dimensional view of revenue prospects across all sub-buckets.
By Diet: low-calorie, high-protein, portion-controlled meals; functional beverages such as green tea and slimming waters, or ready-to-drink protein shakes; dietary supplements like fat burners for weight loss boost strategies, meal replacement shakes, herbal formulations. The highly personalized nature of diet plans based on health profiles is rapidly gaining traction, enabling meal delivery and clinical nutrition programs to scale across developed and developing markets alike.
By Type: The fitness equipment segment, the second-largest segment, is growing faster and fueled by the home gym boom caused during the pandemic (followed by continued demand for connected fitness experiences). Treadmills, stationary bikes and elliptical trainers constitute the lead share well within this sub-segment owing to their calorie-burning efficiency and prevalence across home and commercial gym settings. Stuff like strength training equipment and smart fitness trackers also belong to this bucket as well.
Based on Type: Surgical Equipment ‐ Minimally Invasive and Non-Invasive Bariatric Devices is a high value niche segment which continues to grow in parallel with increasing volumes of bariatric surgery across the globe. Leaders in this area include Apollo Endosurgery and Ethicon, with sophisticated surgical tools for laparoscopic and endoscopic weight loss procedures.
Based on Services: The services segment consists of health clubs, fitness centers, commercial weight loss centers, online weight loss programs, and consulting services. Health Clubs represent the largest segment within services, which offer multi-modal fitness and wellness programs. The most rapid sub-segment of the market is weight loss programs because of telehealth expansion, widespread adoption of digital coaching into healthcare and the use of personalized guidance platforms through Artificial Intelligence (AI) technology.
Regional Insights
North America (Dominant Region & Fastest Growing): North America is the dominant region in the global weight management market and is also expected to achieve the fastest CAGR of 10.45% during the forecast period. In the United States specifically, this dominance is driven by an obesity epidemic at critical levels over 40% of adults are categorized by BMI as having obesity according to CDC data. The area is staffed with robust healthcare infrastructure, high penetration for covering obesity-related injunctive medications, early adoption of GLP-1 pills and a developed market system that consumers numerous dietary supplements and fitness products. With 80% of adults wanting to live healthier, the U.S. weight loss sector had a USD 3.4 billion-dollar value just in 2023 alone; such market is boundless. Key brands that maintain their headquarters in this region include WW International, Herbalife and Medifast (an upscale diet food company) as well as Nutrisystem, reinforcing North American leadership.
Asia-Pacific (Emerging Powerhouse): Asia-Pacific is the second-largest regional market and led the global weight management revenue at nursing2017 conference media more than 37.68% in 2022. Urbanization, sedentary lifestyles and the mass adoption of calorie-dense processed food are driving obesity rates rapidly higher in the region most acutely in China, India, Japan, and South Korea. Market growth is being spurred by rising disposable incomes, a cultural shift towards preventive wellness, and the growing use of structured diet programs as well as fitness centers throughout the region. Such momentum isn’t expected to slow down in the upcoming decade – India is a relatively new growth market for herbal and ayurvedic solutions, with ever-increasing awareness of weight management solutions.
Europe: Europe is a well-established weight management market, and however steadily growing, Germany; UK fit with 23%, France and Italy with 12%; along with Spain cover the main part of regional revenue. Consumers in Europe are increasingly seeking clinically validated, science-based products and services for weight management. The Digital Health Programs, Corporate Wellness Program & Premium Dietary Supplements market is experiencing positive developments across the region. Regulatory scrutiny of GLP-1 drug access and pricing is also a major variable influencing the dynamics for the pharmaceutical segment.
LAMEA (Latin America, Middle East & Africa): LAMEA is emerging as a dynamic new frontier in the weight management marketplace. Brazil is also already #1 in Latin America, buoyed by its health-oriented middle class and growing gym infrastructure. Kao Corporation’s deal with Mitsui & Co. in Brazil comes amidst increasing multinational attention to the market. Demand growth in the Middle East is being fueled by rising wealth, urbanization and a greater appetite for healthier eating among younger populations. Africa is an underserved long-term growth frontier with increasing healthcare access and demand for nutrient/dietary knowledge.
For Purchase Related Queries/Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/A14387
Key Players
The worldwide weight management market is an intense scene, energetically disputable, loaded with the absolute best pharmaceutical businesses to nourishment organizations to wellness organizations, from computerized wellbeing stages and patient adherence arrangements toward medicinal gadget originators. Key companies described in this report are:
Novo Nordisk A/S: Danish biotech giant, creator of Ozempic and Wegovy (semaglutide), the most commercially successful GLP-1 weight management drugs ever commercialized worldwide with major revenue growth along with clinical pipeline expansion into oral formulations
Eli Lilly and Company: Creator of Zepbound and Mounjaro (tirzepatide), Eli Lilly was the first pharma company to break a 1 trillion dollar market cap, aided by demand for GLP-1 weight management drugs worldwide.
Herbalife Nutrition Ltd: A global nutrition and direct-selling firm, Herbalife offers protein shakes, meal substitutes and weight management supplements in 90 countries via an expansive distributor network
WW International, Inc. (WeightWatchers): Leader in behavioral and structured weight loss programs with a recent digital pivot into telehealth by merging with Sequence one year ago, an emerging subscription-based medical weight management platform.
Medifast, Inc: Operators of the OPTAVIA coaching program and other meal replacement and dietary supplement products that are either clinically tested or Doctor recommended focused on the U.S not only medical supervised weight loss space but also positive momentum from their unparalleled clinical evidence.
Nutrisystem, Inc: Weight management service provider that delivers fully prepared, portion-controlled, nutritionally balanced meal plans to millions of consumers in North America.
Nestlé Health Science S.A: World leader in clinical nutrition; they have premium brands like OPTIFAST who focus on medically supervised weight loss programs of both hospital and outpatient nutrition.
Cook, a/Abbott Laboratories: Clinical credibility nutrition science backed weight management and metabolic health products Cross-channel destined delivery.
Apollo Endosurgery, Inc: Apollo specializes in the development of products for surgical interventions with a focus on minimally invasive tools for the treatment and management of obesity through specialized endoscopic suturing devices and intragastric balloons.
Technogym S.p.A: A leading Italian company, which produces and supplies advanced cardio and strength products for premium health clubs, hospitals and the home fitness market globally.
Key Recent Industry Developments
In late December 2025, Novo Nordisk obtained FDA regulatory approval for its oral semaglutide weight management drug with a full commercial rollout in early 2026 A watershed moment as the first oral GLP-1 therapy was to enter the mainstream of the prescription weight management marketplace.
India is home to the world’s second-fastest growing weight management market, so in March 2025, Eli Lilly launched its diabetes and weight-loss drug Mounjaro (tirzepatide) there as a pivotal geographic expansion of this product, which has now achieved over USD 20 billions of cumulative global sales.
In November 2025, the Trump Administration negotiated furnishing price agreements with Eli Lilly and Novo Nordisk for GLP-1 weight-loss medications, cutting the monthly patient cost of the drugs from more than USD 1,000 to as low as USD 245 a month in qualifying cases among Medicare and Medicaid beneficiaries.
WW International (Weight Watchers) purchased Sequence, which offers a telehealth service where physicians supervise the prescription of GLP-1 competitors for medically supervised weight management, combining both pharmaceuticals and behavioral elements into one subscription-based ecosystem.
In November 2023, Herbalife announced the recognition of its Lifestyle Intervention Program by the CDC, as a Certified Diabetes Prevention Program, legitimizing the science-based weight management strategy that can now be made available to new institutional and employer wellness partnerships.
Allurion Technologies then followed suit in November 2024, releasing AllurionMeds, an integrated offering of GLP-1 weight-loss medications with its Coach Iris digital platform clinically proven to support behavior change through access to a virtual dietician and linked smart scale.
In March 2025, Roche and Zealand Pharma announced an exclusive collaboration and licensing deal to co-develop petrelintide (an amylin analog for standalone and combo obesity treatment) expanding the pharmaceutical pipeline enormously in the weight management space.
Research at the University of Southern Denmark recently revealed a previously unknown protein that can turn off brown fat metabolism (April 2024, San Jose) and opened new doors to possible pharmaceutical targets for weight management therapies through metabolic regulation.
Explore AMR’s Extensive Ongoing Coverage on Life Science Industry:
Skincare Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Medical Cannabis Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Healthcare Staffing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Digital Pathology Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Health and Wellness Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of «Market Research Reports» and «Business Intelligence Solutions.» AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Logo – https://mma.prnewswire.com/media/636519/5963419/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/weight-management-market-to-reach-usd-381-5-billion-globally-by-2033-at-10-3-cagr-allied-market-research-302768535.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…